Dacryocystitis Market Size (2024 - 2029)

The dacryocystitis market is projected to experience growth driven by an increase in the prevalence of eye infections and the expansion of clinical research leading to new product launches. This market's expansion is influenced by factors such as the anatomical predisposition of women to the condition and the age demographic most affected, typically individuals in their 50s or 60s. The market's dynamics are further shaped by the relatively rare occurrence of infections like fungal dacryocystitis, which constitutes a small percentage of cases.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Anti-inflammatory Research Dacryocystitis Market Market Size

Market Size of Dacryocystitis Industry

DCT
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 4.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Dacryocystitis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Dacryocystitis Market Analysis

The dacryocystitis market studied is anticipated to register a CAGR of nearly 4.2%, during the forecast period.

Certain factors that are driving the market growth include a rise in the prevalence of eye infections and increasing clinical research and subsequent new product launches.

Dacryoadenitis is an inflammation of the lacrimal gland. Infections are rare and may be acute or chronic. Patients with acute dacryoadenitis suffer from a tender area of erythema and swelling in the lateral part of the upper lid. It may lead to preseptal or orbital cellulitis or may suppurate into an abscess.

As per the study titled 'Fungal infections of the eye', fungal dacryocystitis accounts for approximately 5% of all acquired dacryocystitis and around 14% of cases of congenital dacryocystitis. Women are affected more frequently with all forms of dacryocystitis than men, probably because of anatomically narrower nasolacrimal ducts. It mostly affects individuals in their 50s or 60s.

Dacryocystitis Industry Segmentation

As per the scope of the report, dacryocystitis refers to an infection of the tear sac (lacrimal sac) in the inner corner of the eye. It causes pain, redness, and swelling over the inner aspect of the lower eyelid and epiphora.

By Indication
Acute
Chronic
Other Indications
By Distribution Channel
Institutional Sales
Retail Sales
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Dacryocystitis Market Size Summary

The dacryocystitis market is poised for steady growth, driven by an increase in eye infections and advancements in clinical research leading to new product introductions. Dacryocystitis, characterized by inflammation of the lacrimal sac, can manifest as acute or chronic conditions, with bacterial infections being the primary cause of acute cases. The condition is more prevalent in women, likely due to anatomical differences in the nasolacrimal ducts, and predominantly affects individuals in their 50s and 60s. The market landscape is shaped by a few key players, including Aurobindo Pharma, Bess Medizintechnik GmbH, and Pfizer Inc., who hold significant market shares.

In the United States, there has been a notable increase in dacryocystitis cases, particularly among females, as evidenced by various studies. The regulatory environment and funding opportunities from organizations like the National Institute of Health have encouraged research and development in this field. The competitive nature of the market is underscored by the presence of major companies such as Glaxosmithkline PLC and Kaneka Corporation, which contribute to the ongoing innovation and availability of treatment options for dacryocystitis.

Explore More

Dacryocystitis Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rise in Prevalence of Eye Infections

      2. 1.2.2 Increasing Clinical Research and Subsequent New Product Launches

    3. 1.3 Market Restraints

      1. 1.3.1 Less Patient Awareness Regarding Various Treatment Procedures

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Indication

      1. 2.1.1 Acute

      2. 2.1.2 Chronic

      3. 2.1.3 Other Indications

    2. 2.2 By Distribution Channel

      1. 2.2.1 Institutional Sales

      2. 2.2.2 Retail Sales

    3. 2.3 By Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Dacryocystitis Market Size FAQs

The Dacryocystitis Market is projected to register a CAGR of 4.20% during the forecast period (2024-2029)

Pfizer Inc. , Aurobindo Pharma , Orex Pharma Pvt Ltd, Nosch and Mylan NV are the major companies operating in the Dacryocystitis Market.

Dacryocystitis Report Snapshots

Dacryocystitis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)